Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 84 (2) , 152-156
- https://doi.org/10.1016/s0002-9149(99)00225-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The rationale of magnesium as alternative therapy for patients with acute myocardial infarction without thrombolytic therapyAmerican Heart Journal, 1996
- Review of clinical evidence – is there a role for supplemental magnesium in acute myocardial infarction in high-risk populations (patients ineligible for thrombolysis and the elderly)?Coronary Artery Disease, 1996
- Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapyThe American Journal of Cardiology, 1995
- Cod liver oil alters platelet-arterial wall response to injury in pigs.Circulation Research, 1992
- Beneficial effect of magnesium sulfate in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Hypomagnesemia in Patients in Postoperative Intensive CareChest, 1989
- Evidence that prostacyclin mediates the vascular action of magnesium in humans.Hypertension, 1987
- Potassium/magnesium depletion in patients with cardiovascular diseaseThe American Journal of Medicine, 1987
- Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Magnesium MetabolismNew England Journal of Medicine, 1968